Home | Welcome to Contract Pharma   
Last Updated Thursday, July 31 2014
Print RSS Feed

Breaking News

Related Searches:
March 4, 2011
Ventrus Biosciences has selected inVentiv Clinical Solutions to manage its Phase III trial with Iferanserin in development for the treatment of hemorrhoids.   Read More »
March 4, 2011
Dr. Yunxia (Vivian) Bi has been appointed Technical Director of ISP Pharmaceuticals Solubility Initiative.  Read More »
March 4, 2011
Dan DeVido has been appointed business development manager at Pillar5 Pharma, Inc.   Read More »
March 4, 2011
Corgenix Medical Corp. has successfully completed the feasibility stage for a new, high-speed automated test format for its AspirinWorks Test, developed in collaboration with Randox Laboratories.  Read More »
March 3, 2011
Charles River Laboratories and Pfizer have entered into a marketing and distribution agreement to provide certain Pfizer-developed genetically modified research models to the biomedical research community.  Read More »
March 3, 2011
Lycera Corp. and Merck have entered into an exclusive research collaboration to discover, develop and commercialize drug candidates to treat autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis.   Read More »
March 3, 2011
Ricerca Biosciences has entered a strategic partnership with Fulcrum Pharma, an Aptiv Solutions company, to provide value-added capabilities to biopharma companies by creating a streamlined and efficient process to move a drug candidate from development t  Read More »
March 3, 2011
Lyophilization Services of New England, Inc. (LSNE) has recently completed a comprehensive FDA audit of its medical device manufacturing facility in Manchester, NH.   Read More »
March 3, 2011
Amyris, Inc. has entered into a contract manufacturing agreement with Antibióticos, S.A. to produce farnesene at Antibióticos’ facilities in León, Spain.   Read More »
March 3, 2011
Early and Late Stage revenues decline  Read More »
March 2, 2011
Jim McDermott has been appointed managing director of Quintiles’ Market Intelligence Practice for the Consulting group.  Read More »
March 2, 2011
IRX Therapeutics has signed a research collaboration agreement with a leading research-based pharmaceutical company to assess the potential effects of IRX-2 on the tumor microenvironment.  Read More »
March 2, 2011
PTC Therapeutics, through its Wellcome Trust collaboration, has identified a chemical series of molecules that penetrates the blood-brain barrier in animal models and reduces levels of BMI1, a protein linked to drug-resistant cancers.  Read More »
March 2, 2011
Celerion has completed a clean room and pharmacist certification to comply with USP 797 guidelines.  Read More »
March 1, 2011
Clondalkin Group has acquired the Printed Components business of Catalent Pharma Solutions.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On